PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Sinclair & Co.
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Bioptigen Envisu SDOCT Used in Rare Elephant Cataract Surgery - Surgery also marked first time SDOCT used to image elephant -
Bioptigen Envisu SDOCT Used in Rare Elephant Cataract Surgery


NewswireToday - /newswire/ - Raleigh, NC, United States, 2012/02/02 - Surgery also marked first time SDOCT used to image elephant -

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Veterinarians used Bioptigen’s Envisu R2300 ophthalmic imaging system in the successful surgical removal of a cataract from C’sar, a 38-year-old African elephant residing at the North Carolina Zoo.

The surgery in November represented only the fifth time elephant cataract surgery has been performed anywhere in the world. And it marked the first time that a spectral domain optical coherence tomography (SDOCT) imaging system was used on an elephant.

North Carolina Zoo officials say that C’sar’s behavior has improved dramatically since surgery – to the extent that they hope he can resume grazing in one of his three-and-a-half acre savannahs this spring. He has been sheltered within his barn and paddock since last March after cataracts in both eyes essentially blinded him, preventing him from safely and confidently roaming in larger spaces.

Dr. Eric Buckland, president and CEO of Bioptigen, said the company’s Envisu R2300 was a logical choice for C’sar’s surgery because it is the only ophthalmic SDOCT system available commercially with a hand-held scanner – a clear benefit for surgeons working with a supine six-ton elephant.

“Our hand-held technology allowed surgeons to bring the imager to the elephant, which obviously is better than having to bring an elephant to an imager,” Buckland said. “And the attributes of our Envisu system allowed users to modify it for the unique size of an elephant’s eye. No other product on the market can do that.”

The Envisu R2300 allowed veterinarians to visualize the cornea, the cataract and the capsular bag prior to surgery.

Dr. Richard J. McMullen Jr., assistant professor of ophthalmology at the College of Veterinary Medicine at N.C. State University, removed the cataract from C’sar’s eye. It was the first time he used Bioptigen’s Envisu system.

“The biggest difference between OCT and ultrasound is the amount of detail you can see in the cornea, especially within the stroma and epithelium,” he said. “As a surgeon, it was very interesting and useful to have that degree of magnification.”

The four-hour surgery was performed in the zoo’s elephant barn. McMullen and his team had hoped to implant a specially created artificial lens in C’sar’s eye, but damaged tissue could not support it, McMullen said. Had the lens been used, it would have been the first artificial lens implantation ever performed on an elephant.

The lack of a replacement lens means C’sar will see farsighted but should function just fine, McMullen said. He added that artificial lens implantation following cataract removal only recently has been adapted in the horse.

C'sar – the oldest male elephant at the North Carolina Zoo – has lived there longer than any other member of the permanent animal population. With his distinguished lopsided silhouette – one ear has laid flat against his head since childhood – C’sar is a favorite among visitors, said Rod Hackney, zoo spokesman.

Said the zoo’s mammal curator, Guy Lichty,“C’sar’s surgery was highly successful and has dramatically improved his quality of life, even without the replacement lens. We are anxious to give him access to one of the larger exhibits, weather permitting, to see if he can safely negotiate the space and find his way back to the barn before nightfall. If he succeeds, staff and visitors will surely celebrate that day. Otherwise, we’ll have to discuss perhaps operating on his other eye in hopes of further improvement.”

The North Carolina Zoo in Asheboro is recognized as one of the nation’s finest zoos. It was the first American zoo designed from inception around the natural-habitat philosophy of presenting animals and plants in exhibits that closely resemble their wild environments.

The N.C. State University College of Veterinary Medicine is ranked third among the nation’s 28 colleges of veterinary medicine by U.S. News and World Report. Its state-of-the-art Randall B. Terry Jr. Companion Animal Veterinary Medical Center is one of the country’s most advanced veterinary hospitals.

Bioptigen Inc. is an ISO 13485-certified medical device company that develops innovative ophthalmologic imaging technologies. The company has received regulatory approval to market its hand-held Envisu R2000-series systems for pre-clinical use and its C2000-series systems for clinical use within the European Union. Availability of the C2000 series for clinical use in the United States is dependent upon review and market clearance by the U.S. Food and Drug Administration.

Bioptigen’s Envisu R-class systems are ideally suited to non-invasive ophthalmic imaging of animals ranging from zebrafish to elephants. Using low-power, near-infrared light, Envisu generates real-time, depth-resolved, high-resolution images of ocular microstructures from the cornea to the retina.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: Sinclair & Co.


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick NewswireToday Visibility Checker


Distribution / Indexing: [+]

# # #

  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

Bioptigen Envisu SDOCT Used in Rare Elephant Cataract Surgery

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
Publisher Contact: Karen Stinneford - 
919-833-9102 kstinneford[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sinclair & Co. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From Sinclair & Co. / Company Profile

Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ipsen Data Presented During ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs
Global Pharmaceutical Contract Manufacturing Organization Market to Reach 2.14 Billion by 2024 Finds Frost & Sullivan
Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria
Global Bio-based Chemicals Market is Expected to Grow At A CAGR of 16.67% by 2027 According to Inkwood Research
Global Diabetes Drugs Market Forecast 2019-2027 Reports Inkwood Research
Dysport® Now Approved in the UK for Symptomatic Treatment of Upper Limb Spasticity in Children with Cerebral Palsy
Human Microbiome Market to Reach .08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics Finds Frost & Sullivan
BASF Launches Hepacor in Switzerland for the Dietary Management of Non-Alcoholic Fatty Liver Disease
FDA Grants Priority Review to Genentech’s Risdiplam for Spinal Muscular Atrophy
Ipsen Presents New Analyses Utilizing Modern Data Mining Approaches At ISPOR Europe 2019
Global Opioids Drugs Market is Projected to Grow At a CAGR of 2.52% by 2027 Reports Inkwood Research
Global Bio-Based Chemicals Market Projected to Grow At a CAGR of 16.67% by 2027 Finds Inkwood Research
The Global Animal Nutrition Market Projected to Grow At a CAGR of 5.94% by 2027 Finds Inkwood Research
FDA Approves Genentech’s Rozlytrek (entrectinib) for People With ROS1-Positive, Metastatic Non-small Cell Lung Cancer
BTG to Invest in Chinese Medical Isotope Diagnosis and Treatment Company Chengdu New Radiomedicine Technology

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business


Visit  RightITnow, Inc.


  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (